Reprint
Integrative Multi-Omics in Biomedical Research
Edited by
December 2021
178 pages
- ISBN978-3-0365-2582-2 (Hardback)
- ISBN978-3-0365-2583-9 (PDF)
This book is a reprint of the Special Issue Integrative Multi-Omics in Biomedical Research that was published in
Biology & Life Sciences
Medicine & Pharmacology
Summary
Genomics technologies revolutionised biomedicine research, but the genome alone is not sufficient to capture biological complexity. Postgenomic methods, typically based on mass spectrometry, comprise the analysis of metabolites, lipids, and proteins and are an essential complement to genomics and transcriptomics. Multidimensional omics is becoming established to provide accurate and comprehensive state descriptions. This book covers the latest methodological developments for, and applications of integrative multi-omics in biomedical research.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
target identification; target validation; label-free method for drugs; anti-angiogenesis; mechanism of action; receptor tyrosine kinases; curcumin; natural products; lipid; lipidomics; cardiac metaplasia; Barrett’s esophagus; esophageal adenocarcinoma; microbiota; DNA sensing; IFI16; cGAS; innate immunity; protein interactions; virus–host interactions; post-translational modifications; mass spectrometry; proteomics; transcriptomics; multi-omics; multi-omics analysis; study design; bioinformatics; machine learning; analysis flow; lipidomics; metabolomics; multi-omics; planned myocardial infarction (PMI); myocardial infarction (MI); exercise; heart; cheminformatics; batch variations; eicosanoids; fetal calf serum; mass spectrometry; peroxisomes; proteomics; host-pathogen interactions; proteomics; secretome; macrophages; acute myeloid leukemia; HL-60 cell line; ATRA; induced differentiation; transcriptome; proteome; transcription factors; key molecules; regulatory pathway modelling; SRM; endometriosis; inflammation; metabolomics; multi-omics; proteomics; n/a